Cohance Lifesciences Ltd
NSE:COHANCE
Cohance Lifesciences Ltd
NSE:COHANCE
Price:
362.95
INR
1.84%
Market Closed
Market Cap:
₹138.9B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Cohance Lifesciences Ltd
NSE:COHANCE
|
IN |
|
Polyard Petroleum International Group Ltd
HKEX:8011
|
HK |
|
P
|
Permaju Industries Berhad
KLSE:PERMAJU
|
MY |
|
Profilgruppen AB
STO:PROF B
|
SE |
|
S
|
Sumitomo Chemical Co Ltd
TSE:4005
|
JP |
|
Sysco Corp
NYSE:SYY
|
US |
|
H
|
Hoang Anh Gia Lai Agricultural JSC
VN:HNG
|
VN |
|
Electronic Arts Inc
NASDAQ:EA
|
US |
|
Target Corp
NYSE:TGT
|
US |
|
AssetMark Financial Holdings Inc
NYSE:AMK
|
US |
|
X
|
Xiamen Changelight Co Ltd
SZSE:300102
|
CN |
|
L
|
Lotus KFM Bhd
KLSE:LOTUS
|
MY |
Income Statement
Earnings Waterfall
Cohance Lifesciences Ltd
Cohance Lifesciences Ltd
Income Statement
Cohance Lifesciences Ltd
Cohance Lifesciences Ltd
Currency: INR
| Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||||||||||
| Interest Expense |
0
|
0
|
172
|
0
|
0
|
0
|
89
|
0
|
0
|
0
|
61
|
0
|
0
|
0
|
54
|
0
|
0
|
0
|
69
|
0
|
0
|
0
|
102
|
0
|
0
|
0
|
|
| Revenue |
8 482
N/A
|
9 000
+6%
|
8 338
-7%
|
8 746
+5%
|
8 391
-4%
|
9 353
+11%
|
10 097
+8%
|
10 353
+3%
|
10 989
+6%
|
12 155
+11%
|
13 202
+9%
|
13 952
+6%
|
13 726
-2%
|
13 348
-3%
|
13 403
+0%
|
13 491
+1%
|
13 017
-4%
|
11 678
-10%
|
10 514
-10%
|
9 345
-11%
|
9 612
+3%
|
10 485
+9%
|
11 976
+14%
|
15 162
+27%
|
18 141
+20%
|
20 515
+13%
|
|
| Gross Profit | |||||||||||||||||||||||||||
| Cost of Revenue |
(3 387)
|
(3 552)
|
(3 197)
|
(3 628)
|
(3 483)
|
(3 791)
|
(4 153)
|
(4 567)
|
(4 897)
|
(5 537)
|
(5 503)
|
(5 961)
|
(5 919)
|
(5 832)
|
(5 683)
|
(5 796)
|
(5 343)
|
(4 825)
|
(4 326)
|
(4 056)
|
(3 708)
|
(3 213)
|
(3 526)
|
(3 898)
|
(4 789)
|
(5 822)
|
|
| Gross Profit |
5 095
N/A
|
5 448
+7%
|
5 141
-6%
|
5 118
0%
|
4 908
-4%
|
5 562
+13%
|
5 944
+7%
|
5 786
-3%
|
6 092
+5%
|
6 619
+9%
|
7 699
+16%
|
7 991
+4%
|
7 807
-2%
|
7 516
-4%
|
7 720
+3%
|
7 695
0%
|
7 674
0%
|
6 853
-11%
|
6 187
-10%
|
5 289
-15%
|
5 903
+12%
|
7 272
+23%
|
8 450
+16%
|
11 264
+33%
|
13 352
+19%
|
14 693
+10%
|
|
| Operating Income | |||||||||||||||||||||||||||
| Operating Expenses |
(1 325)
|
(1 378)
|
(1 528)
|
(1 425)
|
(1 505)
|
(1 605)
|
(1 856)
|
(1 692)
|
(1 782)
|
(1 847)
|
(2 294)
|
(2 250)
|
(2 314)
|
(2 433)
|
(2 532)
|
(2 357)
|
(2 353)
|
(2 353)
|
(2 642)
|
(2 654)
|
(3 259)
|
(4 178)
|
(5 169)
|
(8 283)
|
(10 472)
|
(12 303)
|
|
| Selling, General & Administrative |
(641)
|
(683)
|
(1 290)
|
(720)
|
(755)
|
(792)
|
(1 428)
|
(800)
|
(822)
|
(859)
|
(1 800)
|
(1 059)
|
(1 114)
|
(1 160)
|
(1 349)
|
(1 127)
|
(1 126)
|
(1 158)
|
(1 597)
|
(1 528)
|
(1 761)
|
(2 065)
|
(3 347)
|
(3 376)
|
(4 124)
|
(4 678)
|
|
| Research & Development |
0
|
0
|
0
|
(31)
|
(69)
|
(96)
|
(111)
|
(103)
|
(102)
|
(97)
|
(104)
|
(102)
|
(86)
|
(87)
|
(86)
|
(84)
|
(108)
|
(109)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Depreciation & Amortization |
(226)
|
(227)
|
(239)
|
(253)
|
(272)
|
(304)
|
(316)
|
(336)
|
(352)
|
(370)
|
(391)
|
(416)
|
(445)
|
(462)
|
(477)
|
(488)
|
(486)
|
(491)
|
(545)
|
(555)
|
(605)
|
(681)
|
(775)
|
(1 092)
|
(1 363)
|
(1 629)
|
|
| Other Operating Expenses |
(458)
|
(468)
|
0
|
(422)
|
(409)
|
(414)
|
0
|
(453)
|
(505)
|
(521)
|
0
|
(673)
|
(669)
|
(724)
|
(619)
|
(658)
|
(633)
|
(596)
|
(500)
|
(571)
|
(893)
|
(1 431)
|
(1 047)
|
(3 815)
|
(4 985)
|
(5 996)
|
|
| Operating Income |
3 770
N/A
|
4 070
+8%
|
3 613
-11%
|
3 693
+2%
|
3 404
-8%
|
3 957
+16%
|
4 088
+3%
|
4 095
+0%
|
4 311
+5%
|
4 772
+11%
|
5 405
+13%
|
5 741
+6%
|
5 493
-4%
|
5 083
-7%
|
5 188
+2%
|
5 339
+3%
|
5 321
0%
|
4 500
-15%
|
3 546
-21%
|
2 635
-26%
|
2 644
+0%
|
3 094
+17%
|
3 281
+6%
|
2 981
-9%
|
2 879
-3%
|
2 390
-17%
|
|
| Pre-Tax Income | |||||||||||||||||||||||||||
| Interest Income Expense |
99
|
97
|
424
|
187
|
251
|
396
|
547
|
590
|
698
|
558
|
515
|
119
|
(47)
|
(53)
|
375
|
(51)
|
(53)
|
(52)
|
481
|
(79)
|
(91)
|
(111)
|
469
|
(209)
|
(280)
|
(338)
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(32)
|
0
|
0
|
0
|
(303)
|
(81)
|
(81)
|
(130)
|
|
| Gain/Loss on Disposition of Assets |
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(2)
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
(1)
|
0
|
0
|
0
|
(1)
|
0
|
0
|
0
|
|
| Total Other Income |
85
|
132
|
7
|
214
|
163
|
163
|
41
|
143
|
190
|
788
|
758
|
976
|
1 035
|
518
|
34
|
460
|
549
|
563
|
64
|
694
|
637
|
650
|
(7)
|
546
|
561
|
465
|
|
| Pre-Tax Income |
3 953
N/A
|
4 299
+9%
|
4 045
-6%
|
4 094
+1%
|
3 818
-7%
|
4 516
+18%
|
4 677
+4%
|
4 827
+3%
|
5 198
+8%
|
6 118
+18%
|
6 676
+9%
|
6 836
+2%
|
6 482
-5%
|
5 548
-14%
|
5 597
+1%
|
5 747
+3%
|
5 816
+1%
|
5 010
-14%
|
4 057
-19%
|
3 248
-20%
|
3 189
-2%
|
3 632
+14%
|
3 439
-5%
|
3 236
-6%
|
3 079
-5%
|
2 387
-22%
|
|
| Net Income | |||||||||||||||||||||||||||
| Tax Provision |
(1 011)
|
(1 122)
|
(875)
|
(928)
|
(841)
|
(982)
|
(1 053)
|
(1 068)
|
(1 210)
|
(1 665)
|
(2 138)
|
(2 274)
|
(2 168)
|
(1 758)
|
(1 484)
|
(1 504)
|
(1 498)
|
(1 302)
|
(1 054)
|
(844)
|
(760)
|
(838)
|
(792)
|
(732)
|
(731)
|
(582)
|
|
| Income from Continuing Operations |
2 942
|
3 176
|
3 170
|
3 166
|
2 977
|
3 534
|
3 623
|
3 759
|
3 988
|
4 453
|
4 538
|
4 563
|
4 313
|
3 790
|
4 113
|
4 243
|
4 318
|
3 709
|
3 003
|
2 405
|
2 429
|
2 794
|
2 648
|
2 504
|
2 348
|
1 805
|
|
| Income to Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
(2)
|
31
|
56
|
130
|
212
|
|
| Net Income (Common) |
2 942
N/A
|
3 176
+8%
|
3 170
0%
|
3 166
0%
|
2 977
-6%
|
3 534
+19%
|
3 623
+3%
|
3 759
+4%
|
3 988
+6%
|
4 453
+12%
|
4 538
+2%
|
4 563
+1%
|
4 313
-5%
|
3 790
-12%
|
4 113
+9%
|
4 243
+3%
|
4 318
+2%
|
3 709
-14%
|
3 003
-19%
|
2 405
-20%
|
2 431
+1%
|
2 792
+15%
|
2 679
-4%
|
2 560
-4%
|
2 479
-3%
|
2 017
-19%
|
|
| EPS (Diluted) |
11.55
N/A
|
12.47
+8%
|
12.45
0%
|
12.43
0%
|
11.69
-6%
|
13.88
+19%
|
14.2
+2%
|
14.76
+4%
|
15.66
+6%
|
17.49
+12%
|
17.79
+2%
|
17.92
+1%
|
16.94
-5%
|
14.88
-12%
|
16.16
+9%
|
16.67
+3%
|
16.98
+2%
|
14.59
-14%
|
11.8
-19%
|
9.46
-20%
|
9.49
+0%
|
10.88
+15%
|
10.47
-4%
|
6.65
-36%
|
6.45
-3%
|
5.27
-18%
|
|
Switch to:
Switch to:
See Also
Discover More
